Introduction to GLP-1 Agonists Glucagon-like peptide-1 (GLP-1) agonists are a class of medications that have gained significant attention in recent years for their ability to manage blood sugar levels and promote weight loss
Related to this, it will be important to determine whether GLP-1R agonists could reduce appetite in individuals with CGL and FPL patients with low leptin
In another 2025 study by Qeadan and colleagues that used electronic health data from over 1.3 million individuals with a history of alcohol use disorder and opioid use disorder, researchers found that individuals with alcohol use disorder (n=817,309) prescribed GLP-1 medications experienced about 50% fewer alcohol intoxication events over the 2-year period compared to patients who didnt receive the medications (Qeadan et al., 2025)
[DOI] [PMC free article] [PubMed] [Google Scholar] 107.Yamaguchi E., Yasoshima Y., Shimura T
It is the varied individual response pattern you would expect from a compound where the dose-response relationship in humans is not yet fully characterized by clinical research.* Pricing, the Guarantee, and Everything You Need to Know Before You Click Buy No surprises at checkout